Site Navigation

Genedata`s Engagement in Research Consortia and Initiatives

SysMAP
Founded and coordinated by leading specialty chemicals producer Degussa AG, the SysMAP consortium exploits novel experimental and computational methods to probe the biological mechanisms underlying industrial fermentation.

BaSysBio
BaSysBio (Bacillus Systems Biology), an integrated systems biology project involving 15 research organizations from nine European countries, will study the global regulation of gene transcription in model bacteria.

HepatoSys
HepatoSys, an interdisciplinary initiative funded in 2003 by leading German research centers, aims to understand the physiology and pathophysiology of the human liver cell using a systems biology approach.

FRISYS
FRISYS, the Freiburg Initiative for Systems Biology, focuses on modelling and systems analysis of signaling processes in growth and differentiation in human cells and a number of model organisms.

Kluyver Centre for Genomics and Industrial Fermentation
Kluyver Centre is a joint industry and academic consortium that applies genomics technology to improve industrial fermentation.

INCA
The Infections and Cancer (INCA) European Commission research initiative focuses on the role of chronic infection in the development of cancer to find new prevention measures and treatments.

InnoMed PredTox
InnoMed PredTox is a joint Industry and European Commission collaboration to improve drug safety. The consortium is composed of 14 pharmaceutical companies, 3 academic institutions and firms providing computational & laboratory resources.

NewGeneris
NewGeneris is an integrated EU project, with the objective to investigate the role of prenatal and early-life exposure to genotoxic chemicals present in food and the environment.

PROLIGEN
The PROLIGEN consortium studies the regenerative capacity of injured kidneys, using information derived from genomics, proteomics, and functional genomics.

REACH: Carcinogenomics
Aim of the European Commission project Carcinogenomics is to develop in vitro methods for assessing the carcinogenic potential of compounds.


Academic Institutions we collaborate with

Friedrich Miescher Institute for Biomedical Research
German Cancer Research Center
National Institutes of Health, USA
National Institute of Technology & Evaluation, Japan
National Cancer Center, Japan
National Cancer Centre Singapore
Scripps Research Institute
University of Cincinatti
Swiss Federal Institute of Technology (ETH), Zürich
University of California, Irvine
University of Freiburg
University of Minnesota
University of Münster
Hochschule Niederrhein
Tokyo University
Hyogo College of Medicine, Japan